Home›Companies›Biotech & Pharma›Topaz Biosciences

Topaz Biosciences, Inc.

Updated Oct 27, 2026·Latest SEC filing Mar 25, 2025·Suggest an edit

About Topaz Biosciences

Topaz Biosciences is a private company based in Emeryville, California, incorporated in 2022 in Delaware. It has reported $1,434,996 raised in one offering on Form D since March 2025. Its chief executive is Oliver Liu.

Funding Rounds (SEC Form D)

First saleFiled with SECAmount soldInvestorsAvg. checkTermsFiling
Mar 11, 2025Mar 25, 2025$1,434,996of $3.1M target8$179KEquityRule 506(b)Form D ↗

First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.

Leadership Team

Executive officers and directors listed on Topaz Biosciences's Form D filed Mar 25, 2025.

OL
Oliver Liu
Chief Executive Officer and director
CH
Caroline Hadfield
Executive officer
JS
Jennifer Shock
Executive officer and director
TS
Teresa Shock
Director

Sources

  1. SECTopaz Biosciences, Inc. filing history